First-line treatment for elevated intraocular pressure (IOP) associated with open-angle glaucoma or ocular hypertension: focus on bimatoprost

References

• AndersonDR1989Glaucoma: The damage caused by pressure. XLVI Edward Jackson Memorial LectureAm J Ophthalmol108485952683792
   PubMed Web of Science ®Google Scholar
• AngAReddyMAShepstoneL2004Long term effect of latanoprost on intraocular pressure in normal tension glaucomaBr J Ophthalmol88630415090413
   PubMed Web of Science ®Google Scholar
• ArmalyMFKruegerDEMaunderLR1980Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual-field defectsArch Ophthalmol982163717447768
   PubMed Web of Science ®Google Scholar
• AungTWongHTYipCC2000Comparison of the intraocular pressure-lowering effect of latanoprost and timolol in patients with chronic angle closure glaucoma: a preliminary studyOphthalmology10711788310857840
   PubMed Web of Science ®Google Scholar
• BrandtJDVanDenburghAMChenK2001Bimatoprost Study Group. Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP: a 3-month clinical trialOphthalmology10810233111382623
   PubMed Web of Science ®Google Scholar
• BrubakerRF2001Mechanism of action of bimatoprost (Lumigan)Surv Ophthalmol45Suppl 4S3475111434937
   PubMed Web of Science ®Google Scholar
• BrubakerRFSchoffEONauCB2001Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamicsAm J Ophthalmol131192411162974
   PubMed Web of Science ®Google Scholar
• CamrasCBTorisCBSjoquistB2004Detection of the free acid of bimatoprost in aqueous humor samples from human eyes treated with bimatoprost before cataract surgeryOphthalmology1112193815582073
   PubMed Web of Science ®Google Scholar
• CarrilloMMNicolelaMT2004Cystoid macular edema in a low-risk patient after switching from latanoprost to bimatoprostAm J Ophthalmol137966815126179
   PubMed Web of Science ®Google Scholar
• ChewPTAungTAquinoMVEXACT Study Group2004IOP reducing effects and safety of latanoprost versus timolol in patients with chronic angle-closure glaucomaOphthalmology1114273415019314
   PubMed Web of Science ®Google Scholar
• ColemanALLernerFBernsteinP2003A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertensionOphthalmology1102362814644719
   PubMed Web of Science ®Google Scholar
• ColemanRASmithWLNarumiyaS1994International union of pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypesPharmacol Rev4620597938166
   PubMed Web of Science ®Google Scholar
• DavidRLivingstonDGLuntzMH1977Ocular hypertension: A long-term follow-up of treated and untreated patientsBr J Ophthalmol6166874588521
   PubMed Web of Science ®Google Scholar
• DaviesSSJuWKNeufeldAH2003Hydrolysis of bimatoprost (Lumigan) to its free acid by ocular tissue in vitroJ Ocul Pharmacol Ther19455412648303
   PubMed Web of Science ®Google Scholar
• De SantisMLuccheseACarducciB2004Latanoprost exposure in pregnancyAm J Ophthalmol138305615289149
   PubMed Web of Science ®Google Scholar
• DoiLMMeloLAPrataJA2005Effects of the combination olf bimatoprost and latanoprost on intraocular pressure in primary open angle glaucoma: a randomized clinical trialBr J Ophthalmol89547915834081
   PubMed Web of Science ®Google Scholar
• DubinerHCookeDDirksM2001Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: a 30-day comparison with latanoprostSur ophthalmol45Suppl 4S35360
   PubMed Web of Science ®Google Scholar
• FechtnerRDKhouriASZimmermanTJ1998Anterior uveitis associated with latanoprostAm J Ophthalmol12637419683147
   PubMed Web of Science ®Google Scholar
• GagliusoDJWangRFMittagTW2004Additivity of bimatoprost or travaprost to latanoprost in glaucomatous monkey eyesArch Ophthalmol1221342715364714
   PubMedGoogle Scholar
• GandolfiSSimmonsSTSturmR2001Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertensionAdv Ther181102111571823
   PubMed Web of Science ®Google Scholar
• GiuffreG1985The effects of prostaglandin F2α in the human eyeGraefes Arch Clin Exp Ophthalmol222139413856545
   PubMed Web of Science ®Google Scholar
• GordonMOBeiserJABrandtJD2002The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucomaArch Ophthalmol1207142012049575
   PubMed Web of Science ®Google Scholar
• GordonYJYatesKAMahFS2003The effects of Xalatan on the recovery of ocular herpes simplex virus type 1 (HSV-1) in the induced reactivation and spontaneous shedding rabbit modelsJ Ocul Pharmacol Ther192334512828841
   PubMed Web of Science ®Google Scholar
• HellbergMRKeTLHaggardK2003The hydrolysis of the prostaglandin analog prodrug bimatoprost to 17-phenyl-trinor PGF2alpha by human and rabbit ocular tissueJ Ocul Pharmacol Ther199710312804054
   PubMed Web of Science ®Google Scholar
• HerndonLWAsraniSGWilliamsGH2002Paradoxical intraocular pressure elevation after combined therapy with latanoprost and bimatoprostArch Ophthalmol120847912049597
   PubMed Web of Science ®Google Scholar
• HollowsFCGrahamPA1966Intraocular pressure, glaucoma, and glaucoma suspects in a defined populationBr J Ophthalmol50570865954089
   PubMed Web of Science ®Google Scholar
• HungPTHsiehJWChenYF2000Efficacy of latanoprost as an adjunct to medical therapy for residual angle-closure glaucoma after iridectomyJ Ocul Pharmacol Ther1643710673130
   PubMed Web of Science ®Google Scholar
• KaufmanHEVarnellEDThompsonHW1999Latanprost increases the severity and recurrence of herpetic keratitis in the rabbitAm J Ophthalmol127531610334345
   PubMed Web of Science ®Google Scholar
• KolkerAE1972Glaucoma family study: ten-year follow-up (preliminary report)Isr J Med Sci81357614647787
   PubMedGoogle Scholar
• KonstasAGKatsimbrisJMLallosN2005Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patientsOphthalmology11226226615691561
   PubMed Web of Science ®Google Scholar
• KonstasAGKozobolisVPTersisI2003The efficacy and safety of the timolol/dorzolamide fixed combination vs latanoprost in exfoliation glaucomaEye1741612579169
   PubMed Web of Science ®Google Scholar
• KonstasAGMylopoulosNKarabatsasCH2004Diurnal intraocular pressure reduction with latanoprost 0.005% compared to timolol maleate 0.5% as monotherapy in subjects with exfoliation glaucomaEye18893915002024
   PubMed Web of Science ®Google Scholar
• KookMSChoHSYangSJ2005Efficacy of latanprost in patients with chronic angle closure glaucoma and no visible ciliary body face: a preliminary studyJ Ocul Pharmacol Ther21758415718831
   PubMed Web of Science ®Google Scholar
• LaibovitzRAVanDenburghAMFelixC2001Comparison of the ocular hypotensive lipid AGN 192024 with timolol: dosing, efficacy, and safety evaluation of a novel compound for glaucoma managementArch Ophthalmol119994100011448321
   PubMed Web of Science ®Google Scholar
• LawSKCaprioliChapter 56: Medical therapy of glaucomaTasmanWJaegerEADuane’s Clinical OphthalmologyBaltimoreLippincott Williams and Wilkins
   Google Scholar
• LawSKColemanAL2000Following the progress of patients with glaucomaComp Ophthalmol Update1319
   Google Scholar
• LawSKSongJFangE2005Feasibility and efficacy of a mass switch from latanoprost to bimatoprost in glaucoma patients in a pre-paid health maintenance organizationOphthalmology11221233016225924
   PubMed Web of Science ®Google Scholar
• LeeYC2005Abdominal cramp as an adverse effect of travoprostAm J Ophthalmol139202315652856
   PubMed Web of Science ®Google Scholar
• LindseyJDToHDWeinrebRN1994Induction of c-fos by prostaglandin F2α in human ciliary smooth muscle cellsInvest Ophthalmol Vis Sci35242508300352
   PubMed Web of Science ®Google Scholar
• McKibbinMMenageMJ1999The effect of once-daily latanoprost on intraocular pressure and pulsatile ocular blood flow in normal tension glaucomaEye1331410396380
   PubMed Web of Science ®Google Scholar
• MastropasquaLCarpinetoPCiancagliniM1999A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucomaOphthalmology106550510080213
   PubMed Web of Science ®Google Scholar
• MaxeyKMJohnsonJLLaBrecqueJ2002The hydrolysis of bimatoprost in corneal tissue generates a potent prostanoid FP receptor agonistSurv Ophthalmol47Suppl 1S344012204699
   PubMed Web of Science ®Google Scholar
• MitraMChangBJamesT2001Drug points. Exacerbation of angina associated with latanoprostBMJ32378311588081
   PubMed Web of Science ®Google Scholar
• MoralesJShihabZMBrownSM2001Herpes simplex virus dermatitis in patients using latanoprostAm J Ophthalmol132114611438068
   PubMed Web of Science ®Google Scholar
• NoeckerRSDirksMSChoplinNT2003Bimatoprost/Latanoprost Study Group. A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and lantanoprost in patients with ocular hypertension or glaucomaAm J Ophthalmol135556312504698
   PubMed Web of Science ®Google Scholar
• ParrishRKPalmbergPSheuWPXLT Study Group2003A comparison of lantaoprost, bimatoprost, and travaprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter studyAm J Ophthalmol13568870312719078
   PubMed Web of Science ®Google Scholar
• PeakASSuttonBM1998Systemic adverse effects associated with topically applied latanoprostAnn Pharmacother3250459562149
   PubMed Web of Science ®Google Scholar
• RichterMKraussAHWoodwardDF2003Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamideInvest Ophthalmol Vis Sci4444192614507888
   PubMed Web of Science ®Google Scholar
• RuloAHGreveELGeijssenHC1996Reduction of intraocular pressure with treatment of latanoprost once daily in patients with normal-pressure glaucomaOphthalmology1031276828764799
   PubMed Web of Science ®Google Scholar
• SaccaSPascottoASiniscalchiC2001Ocular complications of latanoprost in uveitic glaucoma: three case reportsJ Ocul Pharmacol Ther171071311324978
   PubMed Web of Science ®Google Scholar
• SchachtschabelULindseyJDWeinrebRN2000The mechanism of action of prostaglandins on uveoscleral outflowCurr Opin Ophthalmol11112510848216
   PubMedGoogle Scholar
• SharifNAKellyCRCriderJY2002Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptorJ Ocul Pharmacol Ther183132412222762
   PubMed Web of Science ®Google Scholar
• SherwoodMBrandtJBimatoprost Study Groups 1 and 22001Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressureSurv Ophthalmol45Suppl 4S361811434939
   PubMed Web of Science ®Google Scholar
• SihotaRSaxenaRAgarwalHC2004Crossover comparison of timolol and latanoprost in chronic primary angle-closure glaucomaArch Ophthalmol122185914769594
   PubMed Web of Science ®Google Scholar
• SmithSLPruittCASineCS1999Latanoprost 0.005% and anterior segment uveitisActa Ophthalmol Scand776687210634560
   PubMedGoogle Scholar
• SommerA1989Intraocular pressure and glaucomaAm J Ophthalmol10718682913813
   PubMed Web of Science ®Google Scholar
• SommerATielschJMKatzJ1991Relationship between intra-ocular pressure and primary open angle glaucoma in black and white Americans: The Baltimore Eye StudyArch Ophthalmol109109051867550
   PubMed Web of Science ®Google Scholar
• StewartWCKolkerAEStewartJA2003Conjunctical hyperemia in healthy subjects after short-term dosing with latanoprost, bimatoprost, and travoprostAm J Ophthalmol1353142012614748
   PubMed Web of Science ®Google Scholar
• The Eye Diseases Prevalence Research Group2004Prevalence of open-angle glaucoma among adults in the United StatesArch ophthalmol12253253815078671
   PubMed Web of Science ®Google Scholar
• TielschJMSommerAKatzJ1991Racial variations in the prevalence of primary open angle glaucoma. The Baltimore Eye SurveyJAMA266369742056646
   PubMed Web of Science ®Google Scholar
• TopouzisF2006First line versus first choiceInternational glaucoma review supplement735
   Google Scholar
• TorisCBCamrasCBYablonskiME1997Effects of exogenous prostaglandins on aqueous humor dynamics and blood-aqueous barrier functionSurv Ophthalmol41Suppl 2S69759154279
   PubMed Web of Science ®Google Scholar
• van der ValkRWebersCABSchoutenJSAG2005Intraocular pressure-lowering effects of all commonly used glaucoma drugsOphthalmology11211778515921747
   PubMed Web of Science ®Google Scholar
• WandMGilbertCMLiesegangTJ1999Latanoprost and herpes simplex keratitisAm J Ophthalmol127602410334356
   PubMed Web of Science ®Google Scholar
• WarwarREBullockJDBallalD1998Cystoid macular edema and anterior uveitis associated with latanoprost use. Experience and incidence in a retrospective review of 94 patientsOphthalmology10526389479285
   PubMed Web of Science ®Google Scholar
• WestonBC2001Migraine headache associated with latanoprostArch Ophthalmol119300111176999
   PubMed Web of Science ®Google Scholar
• WoodwardDFKraussAHChenJ2001The pharmacology of bimatoprost (Lumigan)Surv Ophthalmol45Suppl 4S3374511434936
   PubMed Web of Science ®Google Scholar
• WoodwardDFKraussAHChenJ2003Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024)J Pharmacol Exp Ther3057728512606640
   PubMed Web of Science ®Google Scholar
• ZhanGLCamrasCBOpereC1998Effect of prostaglandins on cyclic AMP production in cultured human ciliary muscle cellsJ Ocul Pharmacol Ther1445559493782
   PubMed Web of Science ®Google Scholar